Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives (Q37929646)

25 August 2017

1 reference

title

Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives (English)

1 reference

25 August 2017

1 reference

1 reference

Yunpeng Zhao

1

1 reference

25 August 2017

Aijun Zhang

2

1 reference

25 August 2017

Hongxia Du

3

1 reference

25 August 2017

Shuya Guo

4

1 reference

25 August 2017

Bin Ning

5

1 reference

25 August 2017

Shangyou Yang

6

1 reference

25 August 2017

9 September 2011

1 reference

Rheumatology International

25 August 2017

1 reference

25 August 2017

32

1 reference

25 August 2017

4

1 reference

25 August 2017

837-844

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-011-2133-2

25 August 2017

0 references

cites work

Tolerogenic dendritic cells: cytokine modulation comes of age.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cells as targets for therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory t cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Tolerogenic dendritic cells for autoimmune disease and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

The Role of relB in Regulating the Adaptive Immune Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Association of immunoglobulin-like transcript 6 deficiency with Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Tolerogenic dendritic cells and the quest for transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

TH17 cells in development: an updated view of their molecular identity and genetic programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

A role for calreticulin in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Inflammatory bone destruction and osteoimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

IL-23 in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Glycogen synthase kinase-3 and leukemia: restoring the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Regulatory dendritic cells program generation of interleukin-4-producing alternative memory CD4 T cells with suppressive activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

The yin and yang of regulatory T cells and inflammation in RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Development of dendritic cell-based immunotherapy for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Emergent therapies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Dendritic cells: On the move from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Immunomodulatory Dendritic Cells Inhibit Th1 Responses and Arthritis via Different Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2133-2

Apoptotic cells at the crossroads of tolerance and immunity

21 January 2018

1 reference

12 December 2020

Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL

1 reference

12 December 2020

"Senobi" stretch ameliorates asthma symptoms by restoring autonomic nervous system balance

1 reference

12 December 2020

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis

1 reference

12 December 2020

Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB

1 reference

12 December 2020

Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance

1 reference

12 December 2020

Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm

1 reference

12 December 2020

Dendritic cells in tolerance induction for the treatment of autoimmune diseases

1 reference

12 December 2020

Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells

1 reference

12 December 2020

Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditions

1 reference

12 December 2020

Restoring the balance: Harnessing regulatory T cells for therapy in rheumatoid arthritis

1 reference

12 December 2020

Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses

1 reference

12 December 2020

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer

1 reference

12 December 2020

Immunogenic versus tolerogenic dendritic cells: a matter of maturation

1 reference

12 December 2020

Vaccination with collagen-pulsed dendritic cells prevents the onset and reduces the disease severity in the mouse model of spontaneous polychondritis

1 reference

12 December 2020

Dendritic cell apoptosis in the maintenance of immune tolerance

1 reference

12 December 2020

Th1 and Th2 cytokines in organ transplantation: paradigm lost?

1 reference

12 December 2020

Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells

1 reference

12 December 2020

Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4

1 reference

12 December 2020

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis

1 reference

12 December 2020

Correlation between the immunophenotypical presentation of dendritic cells and the clinical response to anti-rheumatic treatment in rheumatoid arthritis

1 reference

12 December 2020

Use of rapamycin in the induction of tolerogenic dendritic cells.

1 reference

12 December 2020

Overview of benefit/risk of biological agents

1 reference

12 December 2020

Hair cell regeneration: an exciting phenomenon...but will restoring hearing and balance be possible?

1 reference

12 December 2020

10.1007/S00296-011-2133-2

Identifiers

DOI

1 reference

25 August 2017

1 reference